Vagilac 4 billion CFU, 10 vaginal capsules

Composition
active ingredient: 1 capsule contains 4 billion active cells (CFU) Lactobacillus acidophilus, Lactobacillus rhamnosus, Streptococcus thermophilus, Lactobacillus delbrueckii subsp. bulgaricus;

excipients: lactose monohydrate, magnesium stearate, ascorbic acid;

capsule shell: gelatin.

Pharmacotherapeutic group
Other drugs used in gynecology.

ATX code G02C X.

Indications
Prevention and treatment as part of the complex therapy of vaginosis of various origins (Trichomonas, bacterial, fungal).

Dosage and administration
The drug is intended for vaginal use.

Applications for the purpose of treatment

For the treatment of acute, chronic, recurrent infectious and inflammatory diseases of the reproductive system in women, Vagilak is prescribed a few days after the start of antibiotic therapy (on the 4th-5th day), and also, if necessary, after its completion. Duration of use – 10 days. 1 capsule at night. Lying down, insert the capsule deep into the vagina.

Use for prevention.

In order to prevent diseases of the reproductive system in women (bacterial vaginosis, candidiasis, trichomoniasis), Vagilac is used from the beginning of the second half of the menstrual cycle for 5 or 10 days. Lying down, insert the capsule deep into the vagina. 1 capsule at night.